Distillery Therapeutics


<div class="articleContainer">
<div class="articleWrapper">
<div class="articleContent">
<h1 class="text title distillery_title" doc-editable="text" data-component-id="doc-1ef7l992d0">Folate receptor-targeting CAR T for ovarian and other cancers</h1><div class="byline ng-tns-c17-4 ng-star-inserted" data-component-id="doc-1ef7l9he70">
    <span class="ng-tns-c17-4" doc-editable="text">By Claire Quang, Staff Writer</span>
</div><div class="date" data-component-id="doc-1ef7l9jmf0">
  <span class="byline" doc-editable="text"></span>
</div></div></div></div>


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

University of Pennsylvania

DISEASE CATEGORY: CancerINDICATION: Ovarian cancer; melanoma; colorectal cancer......

Cancer

Ovarian cancer

Melanoma

Colorectal cancer

Folate receptor 2 (FOLR2) (FR-beta)

Mesothelin (MSLN)

Folate receptor-targeting CAR T for ovarian and other cancers

DISEASE CATEGORY: Cancer<br/>INDICATION: Ovarian cancer; melanoma; colorectal cancer CAR T cells targeting folate receptor FOLR2 could treat ovarian cancer, melanoma and colorectal cancer. Among